23.70 USD
↗ 1.43 (6.42%)AT CLOSE (11:59 AM EDT)
Vor Biopharma Inc. Common Stock
VORNASDAQ • USD
23.62
↘ 0.09 (0.36%)
POST MARKET (AS OF 07:42 PM EDT)
Post Market
AS OF 07:42 PM EDT
23.62
↘ 0.09 (0.36%)
Market: CLOSED
Shares of Vor Biopharma Inc. Common Stock (VOR) are trading at $23.72. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (587.1%), a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Aug 6, 2026.
Open?$22.01
High?$23.79
Low?$21.90
Prev. Close?$22.27
Volume?735.5K
Avg. Volume?1.5M
VWAP?$23.27
Rel. Volume?0.50x
Bid / Ask
Bid?$23.42 × 400
Ask?$23.75 × 500
Spread?$0.33
Midpoint?$23.59
Valuation & Ratios
Market Cap?1.2B
Shares Out?54.2M
Float?13.2M
Float %?24.4%
P/E Ratio?N/A
P/B Ratio?-8.02
EPS?-$16.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Themes
Employees
76
Market Cap
1.2B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-02-05
Address
500 BOYLSTON STREET
BOSTON, MA 02116
Phone: 617-655-6580
BOSTON, MA 02116
Phone: 617-655-6580
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.97Distress
Confidence?56%Low
Short InterestSqueeze Risk
Short % of Float?55.13%Squeeze Risk
Short Interest?7.3M
Days to Cover?4.4
Free Float13.2M
Avg Daily Volume1.7M
Settlement Date2026-07-15
Financial Health
Current Ratio?31.15Strong
Quick Ratio?31.15Strong
Cash Ratio?10.57Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-8.02CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?587.1%STRONG▾
Peers50
S&P97
ROA?-174.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-150651000
Enterprise Value?$1.0B
Fundamentals ratios updated end of day